by GlobeNewsWire | Sep 8, 2015 | Globe Newswire
NIWOT, Colo., Sept. 8, 2015 (GLOBE NEWSWIRE) — Crocs, Inc. (NASDAQ: CROX) today announced that Jeff Lasher, senior vice president and chief financial officer, is leaving the company to pursue other interests. Lasher, who joined Crocs in 2009 and was named chief...
by GlobeNewsWire | Sep 8, 2015 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Sept. 8, 2015 (GLOBE NEWSWIRE) — Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today...
by GlobeNewsWire | Sep 8, 2015 | Globe Newswire
NEW YORK, Sept. 8, 2015 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”), a Fortress Biotech Company, (NASDAQ:FBIO) announced that it filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC) under the...
by GlobeNewsWire | Sep 8, 2015 | Globe Newswire
Single ascending doses of VTP-43742 safe and generally well-tolerated, demonstrated once-daily pharmacokinetics Robust ex vivo biomarker response, suppressing pro-inflammatory IL-17A by more than 90 percent FORT WASHINGTON, Pa., Sept. 8, 2015 (GLOBE NEWSWIRE) —...
by GlobeNewsWire | Sep 8, 2015 | Globe Newswire
TUSTIN, Calif., Sept. 08, 2015 (GLOBE NEWSWIRE) — Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company’s 10.50% Series E Convertible Preferred...
